Contacare Ophthalmics & Diagnostics
⚠️ High Risk
FEI: 3006217304 • Dabhasa, Gujarat • INDIA
FEI Number
3006217304
Location
Dabhasa, Gujarat
Country
INDIAAddress
310b Village Sim, Block No, Dabhasa, Gujarat, India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
STERILITY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to have been prepared, packed or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health.
INVDEVICE
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a device for investigational use for which no exemption has been granted as prescribed by Section 520(g)
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
LACKS FIRM
The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.
FILTH
The article is subject to refusal of admission pursuant to section 801(a)(3) of the FD&C Act in that the article contains potentially hazardous, or otherwise objectionable in light of intended use, microbial adulteration and therefore consists in part of a filthy substance
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 1/22/2025 | 86LZPAID, SURGICAL, VISCOELASTIC | Division of Southeast Imports (DSEI) | |
| 5/2/2018 | 86PMWSTRABISMUS DETECTION DEVICE | 3081INVDEVICE | Division of Southeast Imports (DSEI) |
| 1/19/2018 | 63XBD12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS) | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 1/19/2018 | 63XAY12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS) | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 1/19/2018 | 63XAY12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS) | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 1/9/2018 | 63XAY12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS) | 3761FILTH | Division of Northern Border Imports (DNBI) |
| 6/23/2017 | 65RAK19SODIUM CHLORIDE (REPLENISHER) | 78STERILITY | Division of Southwest Imports (DSWI) |
| 4/21/2014 | 66VDK99MISCELLANEOUS PATENT MEDICINES, ETC. | Chicago District Office (CHI-DO) | |
| 4/21/2014 | 66VDK99MISCELLANEOUS PATENT MEDICINES, ETC. | Chicago District Office (CHI-DO) | |
| 3/7/2014 | 63XCY12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS) | 75UNAPPROVED | Chicago District Office (CHI-DO) |
| 7/12/2013 | 63XIY99DIAGOSTIC AID (DRUGS) N.E.C. | 75UNAPPROVED | Chicago District Office (CHI-DO) |
| 11/9/2012 | 61KCK62HOMATROPINE HYDROBROMIDE (A-CHOLINERGIC) | Chicago District Office (CHI-DO) | |
| 9/14/2012 | 78MRESOLUTION, SODIUM HYALURONATE | 237NO PMA | New Orleans District Office (NOL-DO) |
| 9/14/2012 | 63XDK99DIAGOSTIC AID (DRUGS) N.E.C. | New Orleans District Office (NOL-DO) | |
| 9/14/2012 | 63XCP12FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS) | New Orleans District Office (NOL-DO) | |
| 9/14/2012 | 88LGYTRYPAN BLUE | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 4/23/2012 | 63XCY99DIAGOSTIC AID (DRUGS) N.E.C. | 333LACKS FIRM | San Juan District Office (SJN-DO) |
| 11/8/2007 | 86LWLFLUID, INTRAOCULAR | Southwest Import District Office (SWI-DO) |
Frequently Asked Questions
What is Contacare Ophthalmics & Diagnostics's FDA import refusal history?
Contacare Ophthalmics & Diagnostics (FEI: 3006217304) has 18 FDA import refusal record(s) in our database, spanning from 11/8/2007 to 1/22/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Contacare Ophthalmics & Diagnostics's FEI number is 3006217304.
What types of violations has Contacare Ophthalmics & Diagnostics received?
Contacare Ophthalmics & Diagnostics has been cited for 12 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Contacare Ophthalmics & Diagnostics come from?
All FDA import refusal data for Contacare Ophthalmics & Diagnostics is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.